Cost-plus to our reps, with the sales director's market read built in. Every line carries a recommended markup and the reasoning behind it. Leadership can edit cost, tune markup by segment, set a target price, flag a status, leave a note — then export the whole call to share. We don't sell on price. We sell on quality, sterility, and supply you can count on.
The read behind the recommended markups. Expand each.
Strategic guidance for internal pricing only — not legal, regulatory, or medical advice. Compounding eligibility and enforcement around GLP-1s have shifted repeatedly; confirm current status with regulatory counsel before finalizing the catalog.
Rep price = cost × (1 + markup), rounded to $5. Competitor toggles drive the market range and the default cost anchor; the cost cell is editable when you know true COGS.
Click any product to expand competitor detail and add a note. Type a leadership target to override the suggestion.
No reliable competitor benchmark in source data — confirm landed cost before publishing.
Both are single live IMPORTRANGE formulas linked to external Google Sheets — they exported as #REF! with no recoverable values, so there was nothing to factor in. Share or paste the source ranges to add them as two more series:
RefDrug → True Cost!A2:J
Greenstone → Greenstone Masterprice!B:F
RD3MG (Rehydra+) added as a sixth series from its clinic price list. Mapped where molecule, concentration, and fill match — its 25 mg/mL tirzepatide, pyridoxine-carrier semaglutide, and 2 mg/mL sermorelin differ from our lines and are left blank. RD3MG also carries a broad peptide / BHRT / vitamin-infusion catalog (BPC-157, CJC-1295, Ipamorelin, GHK-Cu, KPV, MOTS-c, glutathione, B-12, and more) not yet in this workspace — say the word to add those as new lines.
Every chart reflects your current COGS, markup, and leadership prices — they refresh as you edit and recolor with the theme.
Capture rationale, leadership input, and meeting decisions. Timestamped entries are included in every export.